Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolf C Mueller

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Pathology, Research and Practice|December 8, 2014
WHO grade related expression of TRAIL-receptors and apoptosis regulators in meningiomaRonald Koschny, Wolfgang Krupp, Li-Xin Xu, et al.
Clinical Neuropathology|May 1, 2020
Quality assurance in neuropathology: Experiences from the round robin trials on <i>IDH</i> mutation and <i>MGMT</i> promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019Markus J Riemenschneider, Josephine Fischer, Maja Grassow-Narlik, et al.
Journal of Neuropathology and Experimental Neurology|October 8, 2014
Bortezomib sensitizes primary meningioma cells to TRAIL-induced apoptosis by enhancing formation of the death-inducing signaling complexRonald Koschny, Christina Boehm, Martin R Sprick, et al.
The Oncologist|May 24, 2012
A second-generation microRNA-based assay for diagnosing tumor tissue originEti Meiri, Wolf C Mueller, Shai Rosenwald, et al.
The American Journal of Surgical Pathology|September 22, 2023
A Novel Type of IDH-wildtype Glioma Characterized by Gliomatosis Cerebri-like Growth Pattern, TERT Promoter Mutation, and Distinct Epigenetic ProfileAmos Muench, Daniel Teichmann, Dorothee Spille, et al.
Nature Communications|April 18, 2019
Publisher Correction: NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathiesRobert Fledrich, Dagmar Akkermann, Vlad Schütza, et al.
Nature Communications|April 2, 2019
NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathiesRobert Fledrich, Dagmar Akkermann, Vlad Schütza, et al.
Acta Neuropathologica|June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytomaMaja Krech, Amos Muench, Daniel Teichmann, et al.
Acta Neuropathologica|August 6, 2021
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumorsPhilipp Sievers, Sophie C Henneken, Christina Blume, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Pathology, Research and Practice|December 8, 2014
WHO grade related expression of TRAIL-receptors and apoptosis regulators in meningiomaRonald Koschny, Wolfgang Krupp, Li-Xin Xu, et al.
Clinical Neuropathology|May 1, 2020
Quality assurance in neuropathology: Experiences from the round robin trials on <i>IDH</i> mutation and <i>MGMT</i> promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019Markus J Riemenschneider, Josephine Fischer, Maja Grassow-Narlik, et al.
Journal of Neuropathology and Experimental Neurology|October 8, 2014
Bortezomib sensitizes primary meningioma cells to TRAIL-induced apoptosis by enhancing formation of the death-inducing signaling complexRonald Koschny, Christina Boehm, Martin R Sprick, et al.
The Oncologist|May 24, 2012
A second-generation microRNA-based assay for diagnosing tumor tissue originEti Meiri, Wolf C Mueller, Shai Rosenwald, et al.
The American Journal of Surgical Pathology|September 22, 2023
A Novel Type of IDH-wildtype Glioma Characterized by Gliomatosis Cerebri-like Growth Pattern, TERT Promoter Mutation, and Distinct Epigenetic ProfileAmos Muench, Daniel Teichmann, Dorothee Spille, et al.
Nature Communications|April 18, 2019
Publisher Correction: NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathiesRobert Fledrich, Dagmar Akkermann, Vlad Schütza, et al.
Nature Communications|April 2, 2019
NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathiesRobert Fledrich, Dagmar Akkermann, Vlad Schütza, et al.
Acta Neuropathologica|June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytomaMaja Krech, Amos Muench, Daniel Teichmann, et al.
Acta Neuropathologica|August 6, 2021
Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumorsPhilipp Sievers, Sophie C Henneken, Christina Blume, et al.
Pageof 2